The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle
Top Cited Papers
- 1 August 2003
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 24 (4) , 428-465
- https://doi.org/10.1210/er.2002-0005
Abstract
The ovary and uterus undergo extensive tissue remodeling throughout each reproductive cycle. This remodeling of the extracellular environment is dependent upon the cyclic hormonal changes associated with each estrous or menstrual cycle. In the ovary, tissue remodeling is requisite for growth and expansion of the follicle, breakdown of the follicular wall during the ovulatory process, transformation of the postovulatory follicle into the corpus luteum, as well as the structural dissolution of the corpus luteum during luteal regression. In the uterus, there is extraordinary turnover of the endometrial connective tissue matrix during each menstrual cycle. This turnover encompasses the complete breakdown and loss of this layer, followed by its subsequent regrowth. With implantation, extensive remodeling of the uterus occurs to support placentation. These dynamic changes in the ovarian and uterine extracellular architecture are regulated, in part, by the matrix metalloproteinase (MMP) system. The MMP system acts to control connective tissue remodeling processes throughout the body and is comprised of both a proteolytic component, the MMPs, and a regulatory component, the associated tissue inhibitors of metalloproteinases. The current review will highlight the key features of the MMPs and tissue inhibitors of metalloproteinases, focus on the changes and regulation of the MMP system that take place throughout the estrous and menstrual cycles, and address the impact of the dynamic tissue remodeling processes on ovarian and uterine physiology.Keywords
This publication has 339 references indexed in Scilit:
- Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriageFertility and Sterility, 2001
- Effects of Gene Deletion of the Tissue Inhibitor of the Matrix Metalloproteinase-type 1 (TIMP-1) on Left Ventricular Geometry and Function in MiceJournal of Molecular and Cellular Cardiology, 2000
- Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Binds to the Cell Surface and Translocates to the Nucleus of Human MCF-7 Breast Carcinoma CellsBiochemical and Biophysical Research Communications, 1999
- v-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: Requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptorsMolecular Carcinogenesis, 1998
- Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2FEBS Letters, 1996
- Triiodothyronine (T3) modulates hCG-regulated progesterone secretion, cAMP accumulation and DNA content in cultured human luteinized granulosa cellsMolecular and Cellular Endocrinology, 1993
- Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblastsGene, 1992
- mRNA of bovine tissue inhibitor of metalloproteinase: Sequence and expression in bovine ovarian tissueBiochemical and Biophysical Research Communications, 1990
- Inhibition of human collagenase activity by a small molecular weight serum proteinBiochemical and Biophysical Research Communications, 1975
- Collagenase production by human skin fibroblastsBiochemical and Biophysical Research Communications, 1975